sellModerate cluster of 710b5-1 plan
BENKOWITZ MICHAEL sold $6.1M of UTHR
PRESIDENT AND COO at UNITED THERAPEUTICS Corp. 15,000 shares at an average of $407.32, traded Nov 11, 2024, filed Nov 12, 2024.
Warning score
45Value
$6.1M
15,000 shares
Holdings after
0
-133% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001415889-24-026613, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 11, 2024 | MOption exercise Common Stockindirect: By Trust10b5-1 | +11,250 | $102.11 | $1.1M | 11,250 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -741 | $401.02 | $297k | 10,509 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -456 | $402.47 | $184k | 10,053 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,361 | $403.31 | $549k | 8,692 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,142 | $404.31 | $462k | 7,550 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -742 | $405.37 | $301k | 6,808 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -428 | $406.56 | $174k | 6,380 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,381 | $407.77 | $563k | 4,999 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,670 | $409.06 | $683k | 3,329 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -3,030 | $410.54 | $1.2M | 299 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -216 | $410.86 | $89k | 83 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -83 | $412.25 | $34k | 0 | Nov 12, 2024 |
| Nov 11, 2024 | MOption exercise Common Stockindirect: By Trust10b5-1 | +3,750 | $111.00 | $416k | 3,750 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -426 | $405.20 | $173k | 3,324 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -89 | $406.63 | $36k | 3,235 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,294 | $407.82 | $528k | 1,941 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -1,451 | $408.77 | $593k | 490 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -284 | $409.26 | $116k | 206 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -106 | $410.29 | $43k | 100 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -84 | $411.63 | $35k | 16 | Nov 12, 2024 |
| Nov 11, 2024 | SOpen-market sale Common Stockindirect: By Trust10b5-1 | -16 | $412.64 | $6,602 | 0 | Nov 12, 2024 |
| Nov 11, 2024 | MOption exercise Stock Optionsderivativeindirect: By Trust10b5-1 | -11,250 | $0.00 | $0 | 27,000 | Nov 12, 2024 |
| Nov 11, 2024 | MOption exercise Stock Optionsderivativeindirect: By Trust10b5-1 | -3,750 | $0.00 | $0 | 42,000 | Nov 12, 2024 |
Related signals
Other insiders at UNITED THERAPEUTICS Corp and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 45Moderate | sell 310b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 39Weak | sell 3 | UTHR UNITED THERAPEUTICS Corp | Mesa Nilda director | $91k | 255 | |
| 45Moderate | sell 310b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.6M | 10,000 | |
| 60Notable | sell 4 | UTHR UNITED THERAPEUTICS Corp | SULLIVAN LOUIS W director | $9.8M | 26,209 | |
| 45Moderate | sell 410b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 45Moderate | sell 310b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 25Weak | sell 310b5-1 | UTHR UNITED THERAPEUTICS Corp | MAHON PAUL A EVP & GENERAL COUNSEL | $2.9M | 7,700 | |
| 38Weak | sell 210b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 45Moderate | sell 310b5-1 | UTHR UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL PRESIDENT AND COO | $3.7M | 10,000 | |
| 25Weak | sell 410b5-1 | UTHR UNITED THERAPEUTICS Corp | MAHON PAUL A EVP & GENERAL COUNSEL | $2.8M | 7,700 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.